Effects of α1-acid glycoprotein on erythrocyte deformability and membrane stabilization

被引:12
作者
Matsumoto, K
Nishi, K
Tokutomi, Y
Irie, T
Suenaga, A
Otagiri, M
机构
[1] Kumamoto Univ, Fac Pharmaceut Sci, Kumamoto 8620973, Japan
[2] Kumamoto Univ, Sch Med, Kumamoto 8600811, Japan
关键词
alpha(1)-acid glycoprotein; erythrocyte deformability; antioxidant activity; erythrocyte osmotic fragility;
D O I
10.1248/bpb.26.123
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of alpha(1)-acid glycoprotein (AGP) on human erythrocyte membrane were examined in vitro. Bovine and dog AGP, in addition to human AGP or asialo human AGP were used, and the collected data were compared with that for human serum albumin (HSA). A new technique developed by Kikuchi was used to investigate erythrocyte deformability. The addition of AGPs including human AGP facilitated the passage of human erythrocytes with an average diameter of 7.2 mum suspended in phosphate buffered saline (PBS) through a 5 mum wide microchannel; hemolysis was suppressed after the passage. The stabilizing effects of AGPs on membrane were evaluated. Human AGP prevented hemolysis induced by hypotonic phosphate buffer solution. The effects of human AGP on the oxidative changes in erythrocytes exposed to oxygen radicals were investigated. Human AGP protected erythrocytes from H2O2 and prevented the oxidation of dihydrorhodamine 123 to rhodamine 123 from H2O2. We propose that the antioxidant activity of human AGP is due to the binding of free radicals. In all studies, the effects of human AGP on erythrocytes might not be a function of the negative charge associated with sialyl residues, because the presence of N-acetylneuraminic acid had no effect. However, human AGP may promote microcirculation and antioxidant activity compared with HSA. No species differences in the physiological function of AGP were found. These results suggest that an increase in the AGP content of serum above the normal value found under pathological conditions facilitates the passage of erythrocytes through capillaries, stabilizes erythrocyte membranes and protects against oxidative stress, all of which are favorable for microcirculation.
引用
收藏
页码:123 / 126
页数:4
相关论文
共 19 条
  • [1] PREVALENCE OF TRIANTENNARY AND TETRAANTENNARY GLYCANS OF HUMAN ALPHA-1-ACID GLYCOPROTEIN IN RELEASE OF MACROPHAGE INHIBITOR OF INTERLEUKIN-1 ACTIVITY
    BORIES, PN
    FEGER, J
    BENBERNOU, N
    ROUZEAU, JD
    AGNERAY, J
    DURAND, G
    [J]. INFLAMMATION, 1990, 14 (03) : 315 - 323
  • [2] COSTELLO MJ, 1984, CLIN EXP IMMUNOL, V55, P465
  • [3] Functional protection by acute phase proteins α1-acid glycoprotein and α1-antitrypsin against ischemia/reperfusion injury by preventing apoptosis and inflammation
    Daemen, MARC
    Heemskerk, VH
    van 't Veer, C
    Denecker, G
    Wolfs, TGAM
    Vandenabeele, P
    Buurman, WA
    [J]. CIRCULATION, 2000, 102 (12) : 1420 - 1426
  • [4] DEVELOPMENT OF LARGE-SCALE FRACTIONATION METHODS .4. SIMPLE METHOD FOR LARGE-SCALE PREPARATION OF ALPHA1-ACID GLYCOPROTEIN
    HAO, YL
    WICKERHA.M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 322 (01) : 99 - 108
  • [5] Involvement of the acute phase protein α1-acid glycoprotein in nonspecific resistance to a lethal Gram-negative infection
    Hochepied, T
    Van Molle, W
    Berger, FG
    Baumann, H
    Libert, C
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) : 14903 - 14909
  • [6] Human alpha-1-glycoprotein and its interactions with drugs
    Israili, ZH
    Dayton, PG
    [J]. DRUG METABOLISM REVIEWS, 2001, 33 (02) : 161 - 235
  • [7] MODIFIED CELL-FLOW MICROCHANNELS IN A SINGLE-CRYSTAL SILICON SUBSTRATE AND FLOW BEHAVIOR OF BLOOD-CELLS
    KIKUCHI, Y
    SATO, K
    MIZUGUCHI, Y
    [J]. MICROVASCULAR RESEARCH, 1994, 47 (01) : 126 - 139
  • [8] FURTHER CHARACTERIZATION OF THE EFFECTS OF ALPHA-1-ACID GLYCOPROTEIN ON THE PASSAGE OF HUMAN-ERYTHROCYTES THROUGH MICROPORES
    MAEDA, H
    MORINAGA, T
    MORI, I
    NISHI, K
    [J]. CELL STRUCTURE AND FUNCTION, 1984, 9 (03) : 279 - 290
  • [9] CON A-NONREACTIVE HUMAN ALPHA-1-ACID GLYCOPROTEIN (AGP) IS MORE EFFECTIVE IN MODULATION OF LYMPHOCYTE-PROLIFERATION THAN CON A-REACTIVE AGP SERUM VARIANTS
    POS, O
    OOSTENDORP, RAJ
    VANDERSTELT, ME
    SCHEPER, RJ
    VANDIJK, W
    [J]. INFLAMMATION, 1990, 14 (02) : 133 - 141
  • [10] PRIMOZIC S, 1985, J PHARM SCI, V74, P473, DOI 10.1002/jps.2600740421